GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) » Definitions » Operating Margin %

Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) Operating Margin % : 36.49% (As of Mar. 2025)


View and export this data going back to 1999. Start your Free Trial

What is Tibet Rhodiola Pharmaceutical Holding Co Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Tibet Rhodiola Pharmaceutical Holding Co's Operating Income for the three months ended in Mar. 2025 was ¥260 Mil. Tibet Rhodiola Pharmaceutical Holding Co's Revenue for the three months ended in Mar. 2025 was ¥712 Mil. Therefore, Tibet Rhodiola Pharmaceutical Holding Co's Operating Margin % for the quarter that ended in Mar. 2025 was 36.49%.

Good Sign:

Tibet Rhodiola Pharmaceutical Holding Co operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for Tibet Rhodiola Pharmaceutical Holding Co's Operating Margin % or its related term are showing as below:

SHSE:600211' s Operating Margin % Range Over the Past 10 Years
Min: 5.33   Med: 29   Max: 39.75
Current: 37.39


SHSE:600211's Operating Margin % is ranked better than
97.94% of 972 companies
in the Drug Manufacturers industry
Industry Median: 6.97 vs SHSE:600211: 37.39

Tibet Rhodiola Pharmaceutical Holding Co's 5-Year Average Operating Margin % Growth Rate was 7.20% per year.

Tibet Rhodiola Pharmaceutical Holding Co's Operating Income for the three months ended in Mar. 2025 was ¥260 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2025 was ¥1,052 Mil.


Tibet Rhodiola Pharmaceutical Holding Co Operating Margin % Historical Data

The historical data trend for Tibet Rhodiola Pharmaceutical Holding Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tibet Rhodiola Pharmaceutical Holding Co Operating Margin % Chart

Tibet Rhodiola Pharmaceutical Holding Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.42 26.95 29.44 39.21 39.75

Tibet Rhodiola Pharmaceutical Holding Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.90 36.58 31.41 44.86 36.49

Competitive Comparison of Tibet Rhodiola Pharmaceutical Holding Co's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Tibet Rhodiola Pharmaceutical Holding Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tibet Rhodiola Pharmaceutical Holding Co's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tibet Rhodiola Pharmaceutical Holding Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Tibet Rhodiola Pharmaceutical Holding Co's Operating Margin % falls into.


;
;

Tibet Rhodiola Pharmaceutical Holding Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Tibet Rhodiola Pharmaceutical Holding Co's Operating Margin % for the fiscal year that ended in Dec. 2024 is calculated as

Operating Margin %=Operating Income (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=1115.627 / 2806.713
=39.75 %

Tibet Rhodiola Pharmaceutical Holding Co's Operating Margin % for the quarter that ended in Mar. 2025 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2025 ) / Revenue (Q: Mar. 2025 )
=259.846 / 712.109
=36.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tibet Rhodiola Pharmaceutical Holding Co  (SHSE:600211) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Tibet Rhodiola Pharmaceutical Holding Co Operating Margin % Related Terms

Thank you for viewing the detailed overview of Tibet Rhodiola Pharmaceutical Holding Co's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tibet Rhodiola Pharmaceutical Holding Co Business Description

Traded in Other Exchanges
N/A
Address
No. 93, Beijing Middle Road, Tibet Autonomous Region, Lhasa, CHN, 610023
Tibet Rhodiola Pharmaceutical Holding Co is a Chinese company producing biological products and traditional Tibetan medicines.
Executives
Wang Bao Ming senior management
Peng Hui Director
Cao Shu Zhen senior management
Si Qin Director
Ren Bei Chen Supervisors
Liu De Gong Supervisors
Gao Zi Li senior management
Zhou Ming De senior management
Chen Li Ye senior management
Lin Ben Director
Chen Da Bin Director

Tibet Rhodiola Pharmaceutical Holding Co Headlines

No Headlines